📱 Now on iPhone — live scores, valuations & alerts on the go
2 free score cards remaining
X4 Pharmaceuticals, Inc (XFOR)
Healthcare
Model Divergence
weak
$4.04
Updated: 2026-09-05
42
TradeApes Score
Financial Strength
37
Weak
Operating Trend
50
Mixed
Relative Value
10
Overvalued
Capital Allocation
16
Stressed
Risk Management
70
Healthy
Sector Rank
#2558
The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for XFOR.
Key Findings
+
operating-margin trend + inflection
−
earnings yield (absolute)
Industry Related Stocks
Get XFOR and 3,000+ stocks in your pocket
Health scores, fair-value estimates, and full company analysis — free on iPhone.
Download iPhone App
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.